Physician

Charles F Knapp, MD

According to 2025 Medicare claims, Charles Knapp, MD (NPI: 1023246527) practices dermatology in the Wildwood-The Villages, FL market, with the plurality of this provider's patient population coming from Sumter, FL. This provider's primary affiliated billing organization is DERMATOLOGY INSTITUTE AND SKIN CANCER CENTER LLC (NPI: 1891319422; TIN: 85-0782409) and primary practice location at 32163-2005. Knapp is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604), participating under the MSSP model.

Knapp's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,554 traditional Medicare patients, billed 10,297 HCPCS/CPT codes, and received $826,931 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 851 prescription claims across 414 beneficiaries totaling $678,814 in drug costs, led by Otezla (Apremilast). Open Payments data shows 52 records totaling $1,536. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $267,205 to $826,931. Similarly, Part D prescription costs have risen steadily, from $38,895 to $678,814. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$413K$827K2015 Medicare payment: $267,205 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $308,392 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $370,559 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $720,005 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $695,721 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $233,400 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $584,481 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $752,255 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $794,263 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $826,931 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,2234,377$267,205
20161,3984,955$308,392
20171,4016,117$370,559
20181,86711,421$720,005
20191,48110,429$695,721
20208133,958$233,400
20211,1328,143$584,481
20221,47210,285$752,255
20231,62310,471$794,263
20241,55410,297$826,931

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$339K$679K2015 Drug cost: $38,895 (USD; Tot_Drug_Cst)2016 Drug cost: $109,121 (USD; Tot_Drug_Cst)2017 Drug cost: $54,921 (USD; Tot_Drug_Cst)2018 Drug cost: $86,332 (USD; Tot_Drug_Cst)2019 Drug cost: $132,986 (USD; Tot_Drug_Cst)2020 Drug cost: $146,394 (USD; Tot_Drug_Cst)2021 Drug cost: $374,357 (USD; Tot_Drug_Cst)2022 Drug cost: $565,694 (USD; Tot_Drug_Cst)2023 Drug cost: $597,089 (USD; Tot_Drug_Cst)2024 Drug cost: $678,814 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015160368$38,895
2016204429$109,121
2017197378$54,921
2018514944$86,332
20196111,148$132,986
2020308605$146,394
2021390925$374,357
20224411,013$565,694
2023446936$597,089
2024414851$678,814

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths249306$73
11102Biopsy of related skin growth, first growth393534$62
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more584882$61
17000Destruction of precancer skin growth, 1 growth336465$32
88305Pathology examination of tissue using a microscope, intermediate complexity1,0922,630$25

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
OtezlaApremilast16660$106,173
Taltz AutoinjectorIxekizumab12336$85,142
Dupixent PenDupilumab19518$72,807
Clobetasol PropionateClobetasol Propionate1063,187$5,603
FluorouracilFluorouracil431,184$2,474

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.52$1,536ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Charles F. Knapp, MD?

Tedicare shows public-source Medicare data for Charles F. Knapp, MD (NPI 1023246527), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Charles F. Knapp, MD have ACO affiliation data?

Charles F. Knapp, MD is shown with ACO affiliation data for Caravan Collaborative Pathways (MSSP, ACO ID A4604).

What billing organization is linked to Charles F. Knapp, MD?

Charles F. Knapp, MD is linked to DERMATOLOGY INSTITUTE AND SKIN CANCER CENTER LLC (billing NPI 1891319422) in the available physician profile data.

Does Charles F. Knapp, MD have Open Payments data?

Charles F. Knapp, MD has 52 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.